Full name
BBH BIOTECH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
BBH BIOTECH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. IRYSOWA 18, 60-175 POZNAŃ
TAX ID9721248841
Rate company:
BBH BIOTECH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9721248841
KRS0000511561
Share capital26,500.00 zł
address
UL. IRYSOWA 18, 60-175 POZNAŃ
Website
www.bbhbiotech.comCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9721248841
REGON
302690152
KRS
0000511561
Legal form
limited liability company
Register Address
UL. IRYSOWA 18, 60-175 POZNAŃ
Date of registration in KRS
2014-06-04
Date of commencement of economic activity
2014-06-04
Act signature
RDF/678127/24/884
Website
WWW.BBHBIOTECH.COM
Pkd codes
72.11.Z - Research and experimental development on biotechnology
26.6 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
28.9 - Manufacture of other special-purpose machinery
46.7 - Other specialised wholesale
47.9 - Retail trade not in stores, stalls or markets
71.2 - Technical testing and analysis
72.1 - Research and experimental development on natural sciences and engineering
74.9 - Other professional, scientific and technical activities not elsewhere classified
77.4 - Leasing of intellectual property and similar products, except copyrighted works
85.6 - Educational support activities
Payer VAT status
Active
Vat list bank account(s)
PL84 2490 0005 0000 4530 9741 3148 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 47 | -94,5 | -30,3 | 67,9 |
EBITDA | 49,8 | -94,1 | -29,7 | 68,4 |
Short time liabilities | 111,4 | 233,9 | 266,9 | 14,1 |
Equity capital | -30,8 | -125,3 | -155,6 | -24,2 |
Operating profit (EBIT) | 47,2 | -94,1 | -29,7 | 68,4 |
Assets | 80,6 | 108,6 | 116,4 | 7,1 |
Net profit (loss) | 47 | -94,5 | -30,3 | 67,9 |
Cash | 11,8 | 4,5 | 24 | 434,3 |
Net income from sale | 191,2 | 159,7 | 129,8 | -18,7 |
Liabilities and provisions for liabilities | 111,4 | 233,9 | 272 | 16,3 |
Working assets | 80,6 | 108,6 | 116,4 | 7,1 |
Depreciation | 2,5 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -152,6 | 75,4 | 19,5 | -55,9 |
Equity capital to total assets | -38,2 | -115,3 | -133,7 | -18,4 |
Gross profit margin | 24,6 | -59,1 | -23,3 | 35,8 |
EBITDA Margin | 26 | -58,9 | -22,9 | 36 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 213 | 534 | 750 | 216 |
Current financial liquidity indicator | 0.7233793139457703 | 0.4644305408000946 | 0.42788851261138916 | -0,1 |
Net dept to EBITDA | -0.23627053201198578 | -1.3442485332489014 | -4.6454854011535645 | -3,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download xml01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download xmlShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Mariusz Rogała
GDAŃSK
FRONTLINE BIOSCIENCES SPÓŁKA AKCYJNA
WARSZAWA
LIFESPAN MOLECULES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
BIELANY WROCŁAWSKIE
JAROSZ BOŻENA
Lublin
KATARZYNA KRZYSTANEK
Częstochowa